Michael J. Fox Foundation
The assay could allow clinicians to diagnose synucleinopathies like Parkinson's disease without requiring a lumbar puncture to collect cerebrospinal fluid.
NIH Launches Parkinson's Disease Research Partnership
The partnership includes biopharmaceutical, life science, and non-profit organizations, as well as several US government agencies.